| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 04/09/1996 | US5506133 Polypeptide |
| 04/09/1996 | US5505945 Method and compositions for the direct concentrated delivery of passive immunity |
| 04/09/1996 | US5505943 Compositions containing protease produced by vibrio and method of use in debridement and wound healing |
| 04/09/1996 | US5505715 Iontophoretic transdermal delivery of deoxyspergualin compounds |
| 04/04/1996 | WO1996010028A1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE |
| 04/04/1996 | WO1996010013A1 Five membered heterocyclic compounds |
| 04/04/1996 | CA2200210A1 Pyrrolo[2,3-d]pyrimidines and their use |
| 04/03/1996 | EP0704220A1 Use of medicine containing beta interferon |
| 04/03/1996 | EP0704213A1 Dermatologic compositions containing fatty-acid glycerides for the treatment of superinfections |
| 04/03/1996 | EP0704211A2 Preventive or alleviating agent for medical symptoms caused by delayed allergy reactions |
| 04/03/1996 | EP0704209A1 Transdermally active pharmaceutical composition containing 5-aminolaevulinic acid |
| 04/03/1996 | EP0703985A1 Recombinant stratum corneum chymotryptic enzyme (scce) |
| 04/03/1996 | EP0703897A1 Lipoxin compounds |
| 04/03/1996 | EP0703776A1 Utilization of a peptide having a lysin group and an alanine group in the terminal position for the preparation of a depigmenting composition, and depigmenting composition thus obtained |
| 04/03/1996 | EP0458861B1 Composition for reparation and prevention of fibrotic lesions |
| 04/02/1996 | US5504216 Method for reparing an amorphous sulfonamide |
| 04/02/1996 | US5504215 Substituted pyrazolyl benzenesulfonamide compounds for the treatment of inflammation |
| 04/02/1996 | US5504084 Pharmaceutical for the treatment of skin disorders |
| 04/02/1996 | US5504068 Topical preparations containing cyclosporin |
| 04/02/1996 | US5503848 Topical dose of sterile, slow-release, lyophilized non-crosslinked hyaluronic acid ester; wound healing agents, ears |
| 03/28/1996 | WO1996009297A1 Compositions and methods for treating mast-cell inflammatory condition |
| 03/28/1996 | WO1996009055A1 New use of prostaglandins |
| 03/28/1996 | WO1996009048A1 Use of 2,4-diamino pyrimidine 3-oxide or a salt thereof for treating collagen maturation and structuring disorders |
| 03/28/1996 | WO1996009046A1 5α-REDUCTASE INHIBITORS |
| 03/28/1996 | WO1996009044A1 Compositions useful for the preparation of medicines for treating a variety of intractable disorders |
| 03/28/1996 | DE4434312A1 Antimycotic cosmetic and dermatological compsns. |
| 03/28/1996 | DE19515609C1 Prepn. for hair and scalp care contg. alcoholic extract of oat grains or oatmeal |
| 03/28/1996 | CA2200561A1 Compositions and methods for treating mast-cell inflammatory conditions |
| 03/27/1996 | EP0703221A1 5 alpha-reductase Inhibitors |
| 03/27/1996 | EP0702950A1 Use of fatty acids against skin superinfections |
| 03/27/1996 | EP0702554A1 Use of an mhc class i suppressor drug for the treatment of autoimmune diseases and transplantation rejection |
| 03/27/1996 | EP0702551A1 Compositions and methods for reparation and prevention of fibrotic lesions |
| 03/27/1996 | EP0662836A4 Germicidal detergent-iodine compositions having reduced detergent content. |
| 03/27/1996 | CN1119118A Pifule medicine for curing skin disease and producing process thereof |
| 03/27/1996 | CN1119098A Sunning protecting cosmetic composition based on light filing agent efficiency increasing mixture and use of same |
| 03/26/1996 | US5502077 Fatty acid composition |
| 03/26/1996 | US5502075 Leukotriene-B4 derivatives, process for their production and their use as pharmaceutical agents |
| 03/26/1996 | US5502072 Substituted oxindoles |
| 03/21/1996 | WO1996008569A2 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof |
| 03/21/1996 | WO1996008480A1 Neurokinin antagonists |
| 03/21/1996 | WO1996008256A1 2',5' phosphorothioate/phosphodiester oligoadenylates and antiviral uses thereof |
| 03/21/1996 | WO1996008248A1 Compositions for the treatment of skin disorders |
| 03/21/1996 | WO1996008240A1 Use of aromatic halides for treating mammalian cell proliferation |
| 03/21/1996 | WO1996008231A1 Control of hair growth |
| 03/21/1996 | CA2200085A1 Control of hair growth |
| 03/21/1996 | CA2200083A1 Neurokinin antagonists |
| 03/21/1996 | CA2199867A1 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof |
| 03/21/1996 | CA2158724A1 Transdermally active pharmaceutical composition containing 5-aminolaevulinic acid |
| 03/20/1996 | EP0702013A2 Imidazopyridines |
| 03/20/1996 | EP0702012A1 Substituted isoxazole sulfonamides and their use as endothelin antagonists |
| 03/20/1996 | EP0701814A2 Cosmetic or dermatologic composition containing hydrophobised inorganic pigment to maintain the amount of the skin urocanic acid |
| 03/20/1996 | EP0701616A1 Multicistronic expression of recombinant genes in bacterial cells |
| 03/20/1996 | EP0701568A1 New peptide derivatives |
| 03/20/1996 | EP0701565A1 New prednisolone derivates |
| 03/20/1996 | EP0701443A1 Terfenadine metabolites and their optically pure isomers for treating allergic disorders |
| 03/20/1996 | EP0701439A1 Stable copper(i) complexes and methods related thereto |
| 03/20/1996 | EP0449973B1 Polypeptide-polymer conjugates active in wound healing |
| 03/20/1996 | CN1118691A Ointment for treatment of itching disease |
| 03/19/1996 | US5500442 Cyclobut-3-ene-1,2-dione derivatives as smooth muscle relaxants |
| 03/19/1996 | US5500429 Cardiovascular |
| 03/19/1996 | US5500414 Derivatives of peptides usable as inhibitors of bacterial collagenases |
| 03/19/1996 | US5500412 Selective stimulation and inhibition of receptor signals, wound healing, antitumor agents |
| 03/19/1996 | CA2109800C N-hydroxyurea derivatives which inhibit lipoxygenase |
| 03/16/1996 | CA2158225A1 Imidazopyridines |
| 03/14/1996 | WO1996007657A1 Pyrimido[5,4-d]pyrimidines, drugs containing these compounds, their use, and process for preparing them |
| 03/14/1996 | WO1996002229A3 Soap composition |
| 03/13/1996 | EP0700898A1 L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses |
| 03/13/1996 | EP0700897A1 L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses |
| 03/13/1996 | EP0700896A1 Photochemically cleavable metal chelating agents and compositions containing them |
| 03/13/1996 | EP0700304A1 Improved detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates |
| 03/13/1996 | EP0700282A1 Inhibition of hair growth |
| 03/13/1996 | EP0489108B1 Use of spiperone derivatives for immunosuppression |
| 03/13/1996 | CN1118251A Skin spraying sterilizing agent |
| 03/13/1996 | CN1031242C 化妆品组合物 Cosmetic composition |
| 03/12/1996 | US5498745 Antiallergen intermediates, inhibitors of leukotrienes, lipoxygenase inhibitors |
| 03/09/1996 | CA2157837A1 L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses |
| 03/07/1996 | WO1996006640A1 Bioadhesive-wound healing composition |
| 03/07/1996 | WO1996006532A1 A basic protein composition for killing or inhibiting microbial cells |
| 03/07/1996 | WO1996006528A1 Ionene polymers containing biologically-active anions |
| 03/07/1996 | CA2194876A1 Bioadhesive-wound healing composition |
| 03/06/1996 | EP0699439A2 Treatment of diseases caused by sebaceous gland disorders with acyl CoA cholesterol acyl transferase inhibitors |
| 03/06/1996 | EP0699437A1 Pharmaceutical preparations containing polyunsaturated fatty acids, their esters or salts, together with antioxidant vitamins or provitamins |
| 03/06/1996 | EP0699432A1 Cosmetic and/or dermatologic composition containing thermal or mineral water and an active agent against acnee or ageing |
| 03/06/1996 | EP0699428A1 Cosmetic or dermatological composition comprising encapsulated extracts of cornflour |
| 03/06/1996 | EP0590096B1 Process for preparing optically active cyanohydrins with enzymes |
| 03/06/1996 | EP0542802B1 Stimulation of hair growth with potassium channel openers and 5-alpha-reductase inhibitors |
| 03/06/1996 | EP0362259B1 Method of producing cystatin c or modifications hereof and dna-sequence for use when carrying out the method |
| 03/06/1996 | CN1118135A Compositions against skin impurities containing Di- or triglycerine esters as active principle |
| 03/06/1996 | CN1031193C Polypeptide and method for preparing same |
| 02/29/1996 | WO1996006169A1 Human chemokine beta-9 |
| 02/29/1996 | WO1996006083A1 2-(piperazinyl-1-carbonylmethyl)-1,4-dihydropyridines as bradykinin antagonists |
| 02/29/1996 | WO1996006082A1 Dihydropyridine derivatives as bradykinin antagonists |
| 02/29/1996 | WO1996005857A1 Device for delivery of substances and methods of use thereof |
| 02/29/1996 | WO1996005856A1 Human chemokine polypeptides |
| 02/29/1996 | WO1996005838A2 Combined preparation for the therapy of immune diseases |
| 02/29/1996 | WO1996005826A1 Methods of reducing scarring in wound healing |
| 02/29/1996 | WO1996005816A1 Treatment of animals |
| 02/29/1996 | DE4430128A1 Kombinationspräparat mit immunsuppressiven, kardiovaskulären und cerebralen Wirkungen Combination with immunosuppressive drug, cardiovascular and cerebral effects |
| 02/29/1996 | CA2198452A1 Treatment of animals |
| 02/29/1996 | CA2198206A1 Human chemokine beta-9 |